Genital Warts Treatment Market, by Drug Type (Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America,

Genital Warts Treatment Market, by Drug Type (Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Genital warts are a common sexually transmitted infection (STI) that is passed on by vaginal and anal intercourse, sharing sex toys, and rarely, by oral sex. There are various treatments that are available for the treatment of genital warts, which include cream or liquid ointments, surgery for removing warts, etc.
Market players are focusing on research activities for the development of treatment for genital warts. This is expected to aid in the growth of the global genital warts treatment market over the forecast period.
For instance, in November 2021, Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced positive results for its Phase II CARE-1 clinical study of VP-102, a novel topical therapy containing a solution of 0.7% (w/v) cantharidin in a proprietary single-use applicator, developed for the treatment of external genital warts (EGW).
VP-102 achieved positive results on both the primary endpoint of complete clearance of all treatable EGW.
Market Dynamics
Market players and research institutes are indulged in conducting research and development, in order to develop treatment for genital warts. This is expected to increase the growth of the global genital warts treatment market over the forecast period.
For instance, in July 2018, Cassiopea SpA, a specialty pharmaceutical company, announced the availability of proof of concept for its Phase II clinical trial of ‘CB-06-02’, which is a topical 15% immune modulator tellurium-based gel designed for the treatment of genital warts at an extreme level. The proof of concept indicated the complete clearance or statistically significant reduction of genital warts in women. The trial is currently undergoing with various other endpoints.
Key features of the study:
This report provides in-depth analysis of the global genital warts treatment market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global genital warts treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global genital warts treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genital warts treatment market
Detailed Segmentation:
Global Genital Warts Treatment Market, By Drug Type:
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
Global Genital Warts Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Genital Warts Treatment Market, By Region:
North America
By Drug Type
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Drug Type
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Type
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Type
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Drug Type
Imiquimod
Podophyllin and Podofilox
Trichloroacetic Acid
Sinecatechins
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Sanofi S.A.*
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
AbbVie Inc.
Perrigo Company PLC
3M
Lee's Pharmaceutical Holdings Ltd
Cassiopea
Glenmark Pharmaceuticals
Bausch Health
Novartis International AG
“*” marked represents similar segmentation in other categories in the respective section.